Publication

Chronic peptide-based GIP receptor inhibition exhibits modest glucose metabolic changes in mice when administered either alone or combined with GLP-1 agonism

PLoS One 16(3):e0249239, 2021

West JA, Tsakmaki A, Ghosh SS, Parkes DG, Grønlund RV, Pedersen PJ, Maggs D, Rajagopalan H, Bewick GA

Share this page

Resource Library

Related resources

Automated image analyses of glomerular hypertrophy in a mouse model of diabetic nephropathy

The preprohormone expression profile of enteroendocrine cells following Roux-en-Y gastric bypass in rats

Adrenomedullin and glucagon-like peptide-1 have additive effects on food intake in mice

Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese-diabetic mice improves insulin sensitivity associated with recovered pancreatic ß-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries

For further information

Contact us

Gubra

Hørsholm Kongevej 11B
2970 Hørsholm
Denmark

+45 3152 2650